Production (Stage)
InnoCan Pharma Corporation
INNPF
$0.114
-$0.007-5.79%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 38.52% | 28.91% | 25.67% | 53.84% | 12.37% |
Total Receivables | 17.68% | -19.52% | 44.63% | -3.99% | 186.34% |
Inventory | 13.53% | 89.87% | 103.57% | 87.79% | 103.12% |
Prepaid Expenses | -89.33% | -80.29% | -53.94% | -50.60% | 41.99% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 72.26% | 31.93% | -16.67% | 2.94% | 33.01% |
Total Current Assets | 20.18% | 34.44% | 40.78% | 49.20% | 42.43% |
|
|||||
Total Current Assets | 20.18% | 34.44% | 40.78% | 49.20% | 42.43% |
Net Property, Plant & Equipment | -16.41% | -16.91% | -11.94% | -14.08% | -9.22% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 19.66% | 33.43% | 39.75% | 47.68% | 41.29% |
|
|||||
Total Accounts Payable | -62.68% | 65.18% | -60.36% | 119.77% | 65.05% |
Total Accrued Expenses | -- | 3.24% | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -54.55% | -- | -- | -- |
Total Finance Division Other Current Liabilities | -55.08% | -19.58% | 24.93% | 227.87% | 417.34% |
Total Other Current Liabilities | -55.08% | -19.58% | 24.93% | 227.87% | 417.34% |
Total Current Liabilities | -39.27% | -11.99% | 12.85% | 205.96% | 318.78% |
|
|||||
Total Current Liabilities | -39.27% | -11.99% | 12.85% | 205.96% | 318.78% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -93.75% | -84.62% | -73.08% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -9.32% | -12.37% | 12.13% | 197.55% | 309.16% |
|
|||||
Common Stock & APIC | 3.13% | 7.80% | 9.46% | 11.83% | 10.94% |
Retained Earnings | -1.86% | -5.55% | -8.09% | -14.39% | -17.53% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 13.84% | 25.93% | 19.73% | -3.61% | -24.79% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 13.84% | 25.93% | 19.73% | -3.61% | -24.79% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 270.47% | 555.48% | 812.76% | 30,475.00% | 569.29% |
Total Equity | 46.34% | 60.10% | 54.28% | 20.75% | -11.84% |
|